P32249 (GP183_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 120.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: G-protein coupled receptor 183 Alternative name(s): Epstein-Barr virus-induced G-protein coupled receptor 2 Short name=EBI2 Short name=EBV-induced G-protein coupled receptor 2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 361 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for oxysterol 7-alpha,25-dihydroxycholesterol (7-alpha,25-OHC) and other related oxysterols. Binding of 7-alpha,25-OHC mediates the correct localization of B-cells during humoral immune responses. Promotes activated B-cell localization in the outer follicle and interfollicular regions. Its specific expression during B-cell maturation helps position B-cells appropriately for mounting T-dependent antibody responses By similarity. Signals constitutively through G(i)-alpha, but not through G(s)-alpha or G(q)-alpha. Signals constitutively also via MAPK1/3 (ERK1/2). Ref.7 Ref.8 |
| Subcellular location | |
| Tissue specificity | Expressed abundantly in lymphoid tissues such as spleen and lymph node, and in B- and T-lymphocytes. Also highly expressed in lung, heart and gastrointestinal tract, and weakly expressed in the urogenital system and brain. Ref.1 Ref.7 |
| Induction | By Epstein-Barr virus (EBV). Ref.1 |
| Miscellaneous | GSK682753A (8-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-3-[(3,4-dichlorophenyl)methyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one), an inverse agonist, selectively inhibits the constitutive activity of GPR183 with high potency and efficacy (Ref.8). |
| Sequence similarities | Belongs to the G-protein coupled receptor 1 family. |
| Caution | It is uncertain whether Met-1 or Met-5 is the initiator. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 361 | 361 | G-protein coupled receptor 183 | PRO_0000069411 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 31 | 31 | Extracellular Potential | ||||||||
| Transmembrane | 32 – 57 | 26 | Helical; Name=1; Potential | ||||||||
| Topological domain | 58 – 77 | 20 | Cytoplasmic Potential | ||||||||
| Transmembrane | 78 – 95 | 18 | Helical; Name=2; Potential | ||||||||
| Topological domain | 96 – 105 | 10 | Extracellular Potential | ||||||||
| Transmembrane | 106 – 127 | 22 | Helical; Name=3; Potential | ||||||||
| Topological domain | 128 – 149 | 22 | Cytoplasmic Potential | ||||||||
| Transmembrane | 150 – 168 | 19 | Helical; Name=4; Potential | ||||||||
| Topological domain | 169 – 192 | 24 | Extracellular Potential | ||||||||
| Transmembrane | 193 – 215 | 23 | Helical; Name=5; Potential | ||||||||
| Topological domain | 216 – 241 | 26 | Cytoplasmic Potential | ||||||||
| Transmembrane | 242 – 265 | 24 | Helical; Name=6; Potential | ||||||||
| Topological domain | 266 – 287 | 22 | Extracellular Potential | ||||||||
| Transmembrane | 288 – 312 | 25 | Helical; Name=7; Potential | ||||||||
| Topological domain | 313 – 361 | 49 | Cytoplasmic Potential | ||||||||
| Region | 126 – 134 | 9 | Interaction with G proteins | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 328 | 1 | Phosphoserine By similarity | ||||||||
| Disulfide bond | 104 ↔ 181 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 338 | 1 | A → V in an acute myeloid leukemia sample; somatic mutation. Ref.10 | VAR_054147 | |||||||
Experimental info | |||||||||||
| Mutagenesis | 111 | 1 | F → A: 500-fold decrease of IC(50) for GSK682753A. Ref.8 | ||||||||
| Sequence conflict | 6 | 1 | A → V in BAD97110. Ref.3 | ||||||||
| Sequence conflict | 179 | 1 | I → N in BAG36232. Ref.2 | ||||||||
| Sequence conflict | 325 | 1 | R → Q in BAG36232. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors." Birkenbach M.P., Josefsen K., Yalamanchili R.R., Lenoir G.M., Kieff E. J. Virol. 67:2209-2220(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Amygdala. |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Thymus. |
| [4] | "The DNA sequence and analysis of human chromosome 13." Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. Ross M.T.Nature 428:522-528(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Placenta. |
| [7] | "Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity." Rosenkilde M.M., Benned-Jensen T., Andersen H., Holst P.J., Kledal T.N., Luttichau H.R., Larsen J.K., Christensen J.P., Schwartz T.W. J. Biol. Chem. 281:13199-13208(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [8] | "Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonist." Benned-Jensen T., Smethurst C., Holst P.J., Page K.R., Sauls H., Sivertsen B., Schwartz T.W., Blanchard A., Jepras R., Rosenkilde M.M. J. Biol. Chem. 286:29292-29302(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION OF GSK682753A AS AN INVERSE AGONIST, SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF PHE-111. |
| [9] | "Oxysterols direct immune cell migration via EBI2." Hannedouche S., Zhang J., Yi T., Shen W., Nguyen D., Pereira J.P., Guerini D., Baumgarten B.U., Roggo S., Wen B., Knochenmuss R., Noel S., Gessier F., Kelly L.M., Vanek M., Laurent S., Preuss I., Miault C. Sailer A.W.Nature 475:524-527(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION OF OXYSTEROLS AS ENDOGENOUS LIGANDS. |
| [10] | "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome." Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L., Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A., Abbott S. Wilson R.K.Nature 456:66-72(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] VAL-338. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L08177 mRNA. Translation: AAA35924.1. AK292091 mRNA. Translation: BAF84780.1. AK313443 mRNA. Translation: BAG36232.1. AK223390 mRNA. Translation: BAD97110.1. AL160155 Genomic DNA. Translation: CAI14308.1. CH471085 Genomic DNA. Translation: EAX09018.1. BC020752 mRNA. Translation: AAH20752.1. |
| IPI | IPI00027688. |
| PIR | B45680. |
| RefSeq | NP_004942.1. NM_004951.4. |
| UniGene | Hs.784. |
3D structure databases | |
| ProteinModelPortal | P32249. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P32249. 2 interactions. |
| MINT | MINT-1427405. |
| STRING | 9606.ENSP00000365596. |
Protein family/group databases | |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | P32249. |
Polymorphism databases | |
| DMDM | 205371788. |
Proteomic databases | |
| PaxDb | P32249. |
| PeptideAtlas | P32249. |
| PRIDE | P32249. |
Protocols and materials databases | |
| DNASU | 1880. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000376414; ENSP00000365596; ENSG00000169508. |
| GeneID | 1880. |
| KEGG | hsa:1880. |
| UCSC | uc001vog.3. human. |
Organism-specific databases | |
| CTD | 1880. |
| GeneCards | GC13M099946. |
| HGNC | HGNC:3128. GPR183. |
| HPA | CAB033690. HPA028847. |
| MIM | 605741. gene. |
| neXtProt | NX_P32249. |
| PharmGKB | PA162390174. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG145860. |
| HOGENOM | HOG000043070. |
| HOVERGEN | HBG101355. |
| InParanoid | P32249. |
| KO | K04305. |
| OMA | LVFYINT. |
| OrthoDB | EOG4V437Z. |
| PhylomeDB | P32249. |
Gene expression databases | |
| Bgee | P32249. |
| CleanEx | HS_GPR183. |
| Genevestigator | P32249. |
| GermOnline | ENSG00000169508. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000276. GPCR_Rhodpsn. IPR017452. GPCR_Rhodpsn_7TM. IPR002286. P2_purnocptor. [Graphical view] |
| Pfam | PF00001. 7tm_1. 1 hit. [Graphical view] |
| PRINTS | PR00237. GPCRRHODOPSN. PR01157. P2YPURNOCPTR. |
| PROSITE | PS00237. G_PROTEIN_RECEP_F1_1. 1 hit. PS50262. G_PROTEIN_RECEP_F1_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 1880. |
| NextBio | 7689. |
| SOURCE | Search... |
Entry information
| Entry name | GP183_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P32249 Secondary accession number(s): B2R8N5, Q53F99, Q5JUH7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| Human chromosome 13 Human chromosome 13: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
